These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29710555)

  • 21. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
    Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
    BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
    Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
    Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
    Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
    Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular Retinoic Acid Binding Protein 2 (CRABP2), Up-regulated by HPV E6/E7, Leads to Aberrant Activation of the Integrin β1/FAK/ERK Signaling Pathway and Aggravates the Malignant Phenotypes of Cervical Cancer.
    Liu J; Tang L; Chu W; Wei L
    Biochem Genet; 2024 Aug; 62(4):2686-2701. PubMed ID: 38001389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes.
    Lin L; Cai Q; Zhang X; Zhang H; Zhong Y; Xu C; Li Y
    Protein Cell; 2015 Aug; 6(8):575-588. PubMed ID: 25913515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
    Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
    Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Hu J; Liao D; Sun Z; Ren W; Zhao L; Fang Y; Hu K; Yu H; Liu S; Zhou L; He T; Zhang Y
    Carcinogenesis; 2023 May; 44(3):221-231. PubMed ID: 36847693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
    Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
    Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
    Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
    Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus (HPV) oncoprotein E6 facilitates Calcineurin-Nuclear factor for activated T cells 2 (NFAT2) signaling to promote cellular proliferation in cervical cell carcinoma.
    Ram BM; Dolpady J; Kulkarni R; Usha R; Bhoria U; Poli UR; Islam M; Trehanpati N; Ramakrishna G
    Exp Cell Res; 2018 Jan; 362(1):132-141. PubMed ID: 29129565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
    Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
    Au Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-31 functions as an oncogene in cervical cancer.
    Zheng W; Liu Z; Zhang W; Hu X
    Arch Gynecol Obstet; 2015 Nov; 292(5):1083-9. PubMed ID: 25894339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.